Bloomington, Indiana – November 10, 2026 -- Simtra BioPharma Solutions has opened Building H, a more than $250 million expansion of its Bloomington manufacturing campus that adds prefilled syringe, vial and lyophilization capabilities for sterile injectable products.
153,000-square-foot facility adds three production capabilities
The contract development and manufacturing organization (CDMO), which focuses exclusively on sterile injectables, said Building H widens the range of injectable products it can support. Indiana Governor Mike Braun and Bloomington Mayor Kerry Thomson spoke at the ribbon-cutting. The expansion is expected to create hundreds of jobs in Bloomington.
Simtra plans to grow from 11 to 18 filling lines by 2027
Building H is one part of a wider capacity build-out across Simtra's U.S. and European network. The company has invested more than $125 million in expanded manufacturing capacity in Halle, Germany. It has also made an initial investment of more than $150 million at its Bloomington Park Campus. Together, these projects underpin the planned increase from 11 to 18 filling lines by 2027 to meet customer demand.
Executives pitch multi-site flexibility to pharma and biotech clients
Chief Executive Officer Franco Negron said the company is investing in the capacity, technology and infrastructure customers need to develop and manufacture increasingly complex sterile injectable medicines.
Chief Operating Officer Ray Guidotti framed the sites as a menu of options for clients. "Our customers are planning years ahead, and they need manufacturing partners that can do the same," he said. He added that Building H provides new capacity in Bloomington now, alongside the Halle expansion, while the Park campus creates further options for the future. According to Guidotti, the combined footprint gives customers greater flexibility in where and how they manufacture.
Pat Adams, Vice President of Expansion Operations, said the facility combines advanced manufacturing technology with infrastructure designed to support consistent, reliable supply of injectable products.